Co-Diagnostics prices USD 3 million private placement at market under Nasdaq rules

Co-diagnostics

Co-diagnostics

CODX

0.00
  • Co-Diagnostics entered a $3 million at-the-market private placement with institutional investors, selling 1,647,447 common shares or pre-funded warrants.
  • The deal includes warrants to buy up to 3,294,894 common shares, priced with a combined effective offering price of $1.82 per share and warrants.
  • The warrants carry a $1.57 exercise price, are exercisable immediately, and expire five years from issuance.
  • Closing is expected around May 21, 2026, subject to customary conditions.
  • The securities were sold in an unregistered private placement under Section 4(a)(2) and/or Regulation D.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Co-Diagnostics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202605192254PR_NEWS_USPR_____LA63891) on May 20, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.